Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Cardiovascular disease and the risk of lung cancer, the HUNT study

Tore Amundsen, Peter Hatlen, Sven Carlsen, Oyvind Salvesen, Arnulf Langhammer
European Respiratory Journal 2013 42: 4636; DOI:
Tore Amundsen
1Dept. of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Hatlen
1Dept. of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Carlsen
1Dept. of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oyvind Salvesen
1Dept. of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnulf Langhammer
1Dept. of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Inflammation is involved in both lung cancer (LC) and cardio-vascular disease (CVD).

Aims: We hypothesize that CVD is an independent risk factor for LC.

Methods: Data from the Nord-Trøndelag Health Study linked to the Norwegian Cancer and Death Cause Registry, analyses stratified by smoking. 97,087 persons (1,634,967 person years), never smokers n=38,656, former smokers n=20,914, current smokers n=26,894, follow-up 15 years. The proportional hazard model (HR CI 95%) for CVD on LC incidence, adjusted for age, sex, BMI, burden of smoking and chronic cough.

Results: LC = 1,080, cases (1.1%), CVD = 5,981 (6.9%). CVD vs LC in former smokers = HR 1.74 (CI95% 1.11-273), current smokers = HR 1.38 (CI95% 1.04-1.83), never smokers = HR 0.87 (CI95% 03.4-2.23).

View this table:
  • View inline
  • View popup

Table 1

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Conclusion: CVD was an independent risk factor for lung cancer in former and current smokers. CVD may be a novel risk factor for lung cancer screening.

  • Lung cancer / Oncology
  • Epidemiology
  • Comorbidities
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cardiovascular disease and the risk of lung cancer, the HUNT study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Cardiovascular disease and the risk of lung cancer, the HUNT study
Tore Amundsen, Peter Hatlen, Sven Carlsen, Oyvind Salvesen, Arnulf Langhammer
European Respiratory Journal Sep 2013, 42 (Suppl 57) 4636;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Cardiovascular disease and the risk of lung cancer, the HUNT study
Tore Amundsen, Peter Hatlen, Sven Carlsen, Oyvind Salvesen, Arnulf Langhammer
European Respiratory Journal Sep 2013, 42 (Suppl 57) 4636;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
  • Evaluation of response to chemotherapy with fiberoptic bronchoscopy in lung cancers
  • Equal efficacy of gefitinib in chemonaive lung adenocarcinoma patients with either exon 19 deletion or L858R point mutation
Show more 11.1 Lung Cancer

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society